Multiplexed Digital Detection of B-Cell Acute Lymphoblastic Leukemia Fusion Transcripts Using the NanoString nCounter System

J Mol Diagn. 2020 Jan;22(1):72-80. doi: 10.1016/j.jmoldx.2019.08.008. Epub 2019 Nov 13.

Abstract

Chromosomal rearrangements resulting in fusion transcripts have been reported in precursor B-cell acute lymphoblastic leukemia (B-ALL). The identification of fusion events is crucial in the diagnosis of B-ALL. In this study, we used NanoString nCounter technology to design, validate, and evaluate a multiplex panel for the detection of B-ALL fusion transcripts. Fifty-one B-ALL fusion transcripts reported in children in the literature were included in the design of the NanoString panel. Twenty-six fusion transcripts were validated using 64 positive-control samples and 74 negative-control samples with 100% sensitivity and 99% specificity in comparison to RT-PCR. Our results support a potential role of NanoString's technology as a robust and cost-effective technique that could be used in the detection of fusion transcripts and implemented into the diagnostic algorithm of B-ALL.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Biomarkers, Tumor / blood
  • Bone Marrow
  • Cell Line, Tumor
  • Child
  • Chromosome Aberrations
  • Humans
  • Nanotechnology / economics
  • Nanotechnology / methods*
  • Oncogene Proteins, Fusion / blood*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / blood*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
  • RNA / genetics
  • RNA / isolation & purification
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity

Substances

  • Biomarkers, Tumor
  • Oncogene Proteins, Fusion
  • RNA